Ground-breaking Cystic Fibrosis Treatment Is a Testament to Basic Research

Credit: iStock Roughly 70,000 people worldwide have cystic fibrosis (CF)—a progressive, degenerative disease characterized by the buildup of unusually thick mucus in the lungs and other tissues. It occurs when a mutation causes a specific protein, called the cystic fibrosis transmembrane conductance regulator (CFTR), to malfunction. In healthy people, CFTR moves electrolytes in and out … Continue reading Ground-breaking Cystic Fibrosis Treatment Is a Testament to Basic Research